| Makale Türü | Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale) | ||
| Dergi Adı | Atherosclerosis | ||
| Dergi ISSN | 0021-9150 Wos Dergi Scopus Dergi | ||
| Dergi Tarandığı Indeksler | SCI | ||
| Makale Dili | İngilizce | Basım Tarihi | 11-2011 |
| Kabul Tarihi | 12-04-2026 | Yayınlanma Tarihi | – |
| Cilt / Sayı / Sayfa | 219 / 1 / 304–310 | DOI | 10.1016/j.atherosclerosis.2011.06.021 |
| Makale Linki | https://linkinghub.elsevier.com/retrieve/pii/S0021915011005028 | ||
| Özet |
| OBJECTIVES We aimed to investigate the effects of admission asymmetric dimethylarginine (ADMA) levels on myocardial perfusion and prognosis in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI). BACKGROUND ADMA, an endogenous inhibitor of endothelial nitric oxide synthase, was found to be elevated in plasma of patients with cardiovascular risk factors. METHODS 168 consecutive patients undergoing primary PCI for STEMI <12h after symptom onset and 75 healthy age and sex matched volunteer controls were enrolled in the study. Patients with STEMI were grouped into tertiles according to their admission plasma ADMA levels. Major adverse cardiac events during hospitalization or at one-year clinical follow-up were evaluated. Also angiographic impaired reperfusion was assessed by 3 different methods after PCI: angiographic … |
| Anahtar Kelimeler |
| Asymmetric dimethylarginine | ST segment elevation myocardial infarction | Percutaneous coronary intervention | Prognosis |
| Atıf Sayıları | |
| Google Scholar | 39 |
| Web of Science | 27 |
| Dergi Adı | ATHEROSCLEROSIS |
| Yayıncı | Elsevier Ireland Ltd |
| Açık Erişim | Hayır |
| ISSN | 0021-9150 |
| E-ISSN | 1879-1484 |
| CiteScore | 9,6 |
| SJR | 1,762 |
| SNIP | 1,377 |